ECKERT & ZIEGLER SE - DE0005659700 (Stock)
/IBT-BA-HP/WEB-INF/snippets/root/general/name.jsp
45
0
45
67,40 EUR
|
3,3742% |
06.06.2025 08:16
|
- |
- |
- |
- |
/IBT-BA-HP/WEB-INF/snippets/root/general/v2/infobar.jsp
0
1
1
/IBT-BA-HP/WEB-INF/snippets/root/general/toolbar.jsp
0
0
0
/IBT-BA-HP/WEB-INF/snippets/root/stock/navigation.jsp
0
0
0
|
Eckert & Ziegler SE
Robert-Rössle-Strasse 10
13125, Berlin, DE
|
Phone |
+49-30-94-10-84-0 |
Fax |
+49-30-94-10-84-112 |
Email |
info@ezag.de |
Internet |
http://www.ezag.de
|
IR Contact/PR Contact |
-/- |
Symbol |
EUZG |
End of financial year |
31.12.2025 |
Issued capital |
1.312.220.762,75 EUR |
/IBT-BA-HP/WEB-INF/snippets/root/company/contact.jsp
58
0
58
Freefloat |
51,98% |
Andreas Eckert |
31,13% |
JPMorgan Asset Management (UK) Ltd. |
3,01% |
Norges Bank Investment Management |
2,87% |
The Vanguard Group, Inc. |
2,43% |
Janus Henderson Investors UK Ltd. |
2,01% |
Eckert & Ziegler SE |
1,63% |
Capital Research & Management Co. (World Investors) |
1,48% |
Groupama Asset Management SA |
1,44% |
Dimensional Fund Advisors LP |
1,01% |
BlackRock Fund Advisors |
1,00% |
/IBT-BA-HP/WEB-INF/snippets/root/company/shareholders.jsp
67
1
68
Dr. Harald Hasselmann |
Chairman of Managing Board |
Jutta Ludwig |
Member of Executive Committee |
Franklin Yeager |
Member of Executive Committee |
Dr. Gunnar Mann |
Member of Executive Committee |
Dr. Andreas Eckert |
Chairman of Supervisory Board |
Frank Perschmann |
Member of Supervisory Board |
Albert Rupprecht |
Member of Supervisory Board |
Dr. Helmut Grothe |
Member of Supervisory Board |
Dr. Edgar Löffler |
Member of Supervisory Board |
Paola Eckert-Palvarini |
Member of Supervisory Board |
/IBT-BA-HP/WEB-INF/snippets/root/company/board.jsp
1036
0
1036
Activity Description
|
Eckert & Ziegler SE is a holding company, which engages in the processing of radio isotopes. It also focuses on the development, production, and sale of isotope technology components and related products. It operates through the following segments: Isotope Products, Medical, and Other. The Isotope Products segment manufactures and distributes standards, and radiation sources for medical and industrial purposes. The Medical segment offers small radioactive implants for treating prostate cancer and eye applications for treating uveal melanoma. The Other segment focuses pools internal group services like radiation protection, legal, accounting, information technology, and human resources. The company was founded by Andreas Eckert in 1997 and is headquartered in Berlin, Germany.
|
/IBT-BA-HP/WEB-INF/snippets/root/company/corporateactions.jsp
40
0
40